Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights

3 Cannabis Cultivar Plant Patents Applied for by GenCann Inventors

Z-ARCHIVE-Cannabis Patent Forecast®

October 22, 2020

This October, three (3) plant patent applications (US Patent Pub. Nos. 20200329599, ‘600, & ‘601) filed by GenCann, LLC inventors were published for three cannabis cultivars, “V1,” “V2,” and “V3” which contain a higher amount of tetrahydrocannabivarin (THCV) by weight than tetrahydrocannabinol (THC) as well as a unique terpene,  farnesene. 

THCV has shown great therapeutic potential in mice. It can decrease appetite, increase satiety, and up-regulate energy metabolism, making it a potential candidate for weight loss treatments and diabetes management (Abioye et al., 2020). Likewise, farnesene exhibits excellent therapeutic benefits such as anti-inflammation qualities and potentially tumor-inhibition. 

Cannabis cultivar plant patents have been filed for as early as June of 2017, with the first coming from Green Brands, LLC. However, the cannabis cultivar space has come to be dominated by Biotech Institute LLC, and more recently, GenCann. 

GenCann filed three (3) utility patent applications (US Patent. Pub. Nos. 20200323162, ‘163, ‘164) for the cultivars ‘V1,’ ‘V2,’ and ‘V3’ several months after filing for the plant patents. Others in the space, including famed Charlotte’s Web, have also taken to filing utility patents for cannabis plants. Explore the quickly developing Cannabis sector through Magic Number’s Cannabis Patent Forecast® which analyzes and highlights patent and market data. Try it free for one week here!  

green plant in brown pot

Relevant Patent Documents

Application US20200329601  

Application US20200329600  

Application US20200329599  

Z-ARCHIVE-Cannabis   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

For a blog.